Tetra Bio Pharma Inc (TBP.CA) Stock Price & Overview
TSX:TBP • CA88166Y1007
The current stock price of TBP.CA is 0.025 CAD. Today TBP.CA is down by 0%. In the past year, price decreased by -64.29%.
TBP.CA Key Statistics
- Market Cap
- 10.584M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -0.09
- Dividend Yield
- N/A
TBP.CA Stock Performance
TBP.CA Stock Chart
TBP.CA Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to TBP.CA. When comparing the yearly performance of all stocks, TBP.CA is a bad performer in the overall market: 86.45% of all stocks are doing better.
TBP.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to TBP.CA. Both the profitability and financial health of TBP.CA have multiple concerns.
TBP.CA Earnings
TBP.CA Forecast & Estimates
TBP.CA Groups
Sector & Classification
TBP.CA Financial Highlights
Over the last trailing twelve months TBP.CA reported a non-GAAP Earnings per Share(EPS) of -0.09. The EPS increased by 7.3% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
TBP.CA Ownership
TBP.CA Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| BHC | BAUSCH HEALTH COS INC | 1.3 | 2.826B | ||
| CRON | CRONOS GROUP INC | 36.19 | 1.338B | ||
| TLRY | TILRAY BRANDS INC | N/A | 1.125B | ||
| DHT-UN | DRI HEALTHCARE TRUST | 7.43 | 938.393M | ||
| DHT-U | DRI HEALTHCARE TRUST | 5.09 | 643.685M | ||
| GUD | KNIGHT THERAPEUTICS INC | 129.65 | 614.101M | ||
| WEED | CANOPY GROWTH CORP | N/A | 577.777M | ||
| NGEN | NERVGEN PHARMA CORP | N/A | 444.557M | ||
| CPH | CIPHER PHARMACEUTICALS INC | 27.45 | 372.374M | ||
| TSND | TERRASCEND CORP | N/A | 315.605M | ||
| HITI | HIGH TIDE INC | 25.5 | 298.996M | ||
| ACB | AURORA CANNABIS INC | 13.98 | 272.208M | ||
| OGI | ORGANIGRAM GLOBAL INC | 23 | 267.317M |
Related stock screener links
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the Toronto Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the Canadian exchanges | Find stocks with similar Fundamental rating on the Canadian exchanges | Find the competitors with the best technical ratings on the Canadian exchanges | Find the competitors with the best fundamentals on the Canadian exchanges | Find the competitors with the best valuation on the Canadian exchanges | Find the competitors with the best dividend on the Canadian exchanges | Find the competitors with the best analyst ratings on the Canadian exchanges
About TBP.CA
Company Profile
Tetra Bio-Pharma, Inc. engages in the discovery and development of cannabinoid-based drugs and treatments. The company is headquartered in Orleans, Ontario and currently employs 33 full-time employees. The company went IPO on 2008-04-15. The firm has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The firm has a pipeline of formulations and drug delivery systems with a portfolio of assets in early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II study.
Company Info
Tetra Bio Pharma Inc
2316 St-Joseph Blvd.
ORLEANS ONTARIO K1C 1E8 CA
CEO: Richard Giguere
Employees: 33
Phone: 13436890714.0
Tetra Bio Pharma Inc / TBP.CA FAQ
What does TBP do?
Tetra Bio-Pharma, Inc. engages in the discovery and development of cannabinoid-based drugs and treatments. The company is headquartered in Orleans, Ontario and currently employs 33 full-time employees. The company went IPO on 2008-04-15. The firm has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The firm has a pipeline of formulations and drug delivery systems with a portfolio of assets in early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II study.
What is the stock price of Tetra Bio Pharma Inc today?
The current stock price of TBP.CA is 0.025 CAD.
What is the dividend status of Tetra Bio Pharma Inc?
TBP.CA does not pay a dividend.
What is the ChartMill rating of Tetra Bio Pharma Inc stock?
TBP.CA has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
How is the valuation of Tetra Bio Pharma Inc (TBP.CA) based on its PE ratio?
Tetra Bio Pharma Inc (TBP.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.09).
Is Tetra Bio Pharma Inc (TBP.CA) stock a good buy?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on TBP.CA.